Cargando…

Preclinical Assessment of Ursolic Acid Loaded into Nanostructured Lipid Carriers in Experimental Visceral Leishmaniasis

Ursolic acid, a triterpene produced by plants, displayed leishmanicidal activity in vitro and in vivo; however, the low solubility of this triterpene limits its efficacy. To increase the activity of ursolic acid (UA), this triterpene was entrapped in nanostructured lipid carriers (UA-NLC), physical-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jesus, Jéssica Adriana, Sousa, Ilza Maria Oliveira, da Silva, Thays Nicolli Fragoso, Ferreira, Aurea Favero, Laurenti, Márcia Dalastra, Antonangelo, Leila, Faria, Caroline Silvério, da Costa, Paulo Cardoso, de Carvalho Ferreira, Domingos, Passero, Luiz Felipe Domingues
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235317/ https://www.ncbi.nlm.nih.gov/pubmed/34205283 http://dx.doi.org/10.3390/pharmaceutics13060908

Ejemplares similares

Ursolic Acid Potentializes Conventional Therapy in Experimental Leishmaniasis
por: Jesus, Jéssica Adriana, et al.
Publicado: (2020)

Therapeutic effect of ursolic acid in experimental visceral leishmaniasis
por: Jesus, Jéssica A., et al.
Publicado: (2016)

Related Pentacyclic Triterpenes Have Immunomodulatory Activity in Chronic Experimental Visceral Leishmaniasis
por: de Jesus, Jéssica Adriana, et al.
Publicado: (2021)

Corrigendum to “Therapeutic effect of ursolic acid in experimental visceral leishmaniasis” [Int. J. Parasitol. Drugs Drug Resist. 7 (2017) 1–11]
por: Jesus, Jessica A., et al.
Publicado: (2017)

Repurposing Butenafine as An Oral Nanomedicine for Visceral Leishmaniasis
por: Bezerra-Souza, Adriana, et al.
Publicado: (2019)

In situ CUTANEOUS CELLULAR IMMUNE RESPONSE IN DOGS NATURALLY AFFECTED BY VISCERAL LEISHMANIASIS
por: ROSSI, Claudio Nazaretian, et al.
Publicado: (2016)

Evaluating the Potential of Ursolic Acid as Bioproduct for Cutaneous and Visceral Leishmaniasis
por: Bilbao-Ramos, Pablo, et al.
Publicado: (2020)

Serological and infection statuses of dogs from a visceral leishmaniasis-endemic area
por: Laranjeira, Daniela Farias, et al.
Publicado: (2014)

Antimicrobial Activity of Oleanolic and Ursolic Acids: An Update
por: Jesus, Jéssica A., et al.
Publicado: (2015)

Exposure to Leishmania spp. infection and Lutzomyia spp. in individuals living in an area endemic for visceral leishmaniasis in Brazil
por: Hirata, Karina Yukie, et al.
Publicado: (2019)

Efficacy of Spironolactone Treatment in Murine Models of Cutaneous and Visceral Leishmaniasis
por: Andrade-Neto, Valter Viana, et al.
Publicado: (2021)

The Effect of Ursolic Acid on Leishmania (Leishmania) amazonensis Is Related to Programed Cell Death and Presents Therapeutic Potential in Experimental Cutaneous Leishmaniasis
por: Yamamoto, Eduardo S., et al.
Publicado: (2015)

Therapeutic Activity of a Topical Formulation Containing 8-Hydroxyquinoline for Cutaneous Leishmaniasis
por: de Lima, Sarah Kymberly Santos, et al.
Publicado: (2023)

Leishmanicidal Activity and Ultrastructural Changes of Maslinic Acid Isolated from Hyptidendron canum
por: Adriana Jesus, Jéssica, et al.
Publicado: (2021)

High Selectivity of 8-Hydroxyquinoline on Leishmania (Leishmania) and Leishmania (Viannia) Species Correlates with a Potent Therapeutic Activity In Vivo
por: de Lima, Sarah Kymberly Santos, et al.
Publicado: (2023)

New record of preclinical diagnosis of American visceral leishmaniasis in Amazonian Brazil encourages optimizing disease control
por: Lima, Luciana, et al.
Publicado: (2020)

The transmission of visceral leishmaniasis in the municipality of Guarujá, on the Coast of São Paulo state, Brazil
por: Casanova, Claudio, et al.
Publicado: (2022)

Relationship of Serum Antileishmanial Antibody With Development of Visceral Leishmaniasis, Post-kala-azar Dermal Leishmaniasis and Visceral Leishmaniasis Relapse
por: Mondal, Dinesh, et al.
Publicado: (2019)

Further evidence associating IgG1, but not IgG2, with susceptibility to canine visceral leishmaniasis caused by Leishmania (L.) infantum chagasi-infection
por: Lima, Luciana Vieira do R., et al.
Publicado: (2017)

Ultrasound-assisted Extraction of Ursolic Acid from the Flowers of Ixora coccinia Linn (Rubiaceae) and Antiproliferative Activity of Ursolic Acid and Synthesized Derivatives
por: Alves Monteath, Silvana Amadeu Ferreira, et al.
Publicado: (2017)

Visceral leishmaniasis
por: Sundar, Shyam
Publicado: (2015)

How much does it cost to prevent and control visceral leishmaniasis in Brazil? Comparing different measures in dogs
por: Sevá, Anaiá da Paixão, et al.
Publicado: (2020)

Visceral Dissemination of Mucocutaneous Leishmaniasis in a Kidney Transplant Recipient
por: Marques, Nídia, et al.
Publicado: (2020)

Canine visceral leishmaniasis in the Northeast Region of Brazil
por: Brito, Flávio Gonçalves, et al.
Publicado: (2016)

Spatial and spatiotemporal patterns of human visceral leishmaniasis in an endemic southeastern area in countryside Brazil
por: Cruz, Cleya da Silva Santana, et al.
Publicado: (2022)

Evaluation of Rhamnetin as an Inhibitor of the Pharmacological Effect of Secretory Phospholipase A2
por: Novo Belchor, Mariana, et al.
Publicado: (2017)

Comparative Genomic Analyses of New and Old World Viscerotropic Leishmanine Parasites: Further Insights into the Origins of Visceral Leishmaniasis Agents
por: Silveira, Fernando Tobias, et al.
Publicado: (2022)

Spatial and seroepidemiology of canine visceral leishmaniasis in an endemic Southeast Brazilian area
por: Rodrigues, Tamiris Fagundes, et al.
Publicado: (2020)

Expression of inducible nitric oxide synthase in macrophages inversely correlates with parasitism of lymphoid tissues in dogs with visceral leishmaniasis
por: Sanches, Françoise P, et al.
Publicado: (2014)

Congenital Visceral Leishmaniasis
por: Boehme, Catharina C., et al.
Publicado: (2006)

Immunity to Visceral Leishmaniasis
por: Ali, Nahid, et al.
Publicado: (2012)

Treatment of Visceral Leishmaniasis
por: Moore, E M, et al.
Publicado: (2010)

Immunobiology of visceral leishmaniasis
por: Kumar, Rajiv, et al.
Publicado: (2012)

Epidemiology of visceral leishmaniasis
por: Ready, Paul D
Publicado: (2014)

Therapeutic Potential of Photosynthetic Microorganisms for Visceral Leishmaniasis: An Immunological Analysis
por: Vaitkevicius-Antão, Victor, et al.
Publicado: (2022)

Control of visceral leishmaniasis in Brazil: recommendations from Brasileish
por: Ribeiro, Vitor Márcio, et al.
Publicado: (2013)

Sertraline Delivered in Phosphatidylserine Liposomes Is Effective in an Experimental Model of Visceral Leishmaniasis
por: Romanelli, Maiara Maria, et al.
Publicado: (2019)

Nanoemulsified Butenafine for Enhanced Performance against Experimental Cutaneous Leishmaniasis
por: Bezerra-Souza, Adriana, et al.
Publicado: (2021)

Revisiting area risk classification of visceral leishmaniasis in Brazil
por: Machado, Gustavo, et al.
Publicado: (2019)

Monitoring of serum and urinary biomarkers during treatment of canine visceral leishmaniasis
por: Dias, Alvaro Felipe de Lima Ruy, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7jc8sgp4pflneb8uv414dg87ej